Rébécca Phaëton

968 total citations
31 papers, 628 citations indexed

About

Rébécca Phaëton is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Rébécca Phaëton has authored 31 papers receiving a total of 628 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Oncology and 7 papers in Epidemiology. Recurrent topics in Rébécca Phaëton's work include Cervical Cancer and HPV Research (6 papers), Ovarian cancer diagnosis and treatment (6 papers) and Endometrial and Cervical Cancer Treatments (5 papers). Rébécca Phaëton is often cited by papers focused on Cervical Cancer and HPV Research (6 papers), Ovarian cancer diagnosis and treatment (6 papers) and Endometrial and Cervical Cancer Treatments (5 papers). Rébécca Phaëton collaborates with scholars based in United States, Canada and China. Rébécca Phaëton's co-authors include Nadine Hempel, Beth L. Worley, Caroline Chang, Karthikeyan Mythreye, Yeon Kim, Joshua P. Kesterson, Mark H. Einstein, Ekaterina Dadachova, Joshua I. Warrick and Zewei Jiang and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Immunology and Cancer.

In The Last Decade

Rébécca Phaëton

28 papers receiving 616 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rébécca Phaëton United States 13 261 127 107 94 83 31 628
Liyan Huang China 15 213 0.8× 57 0.4× 102 1.0× 63 0.7× 86 1.0× 59 706
Qiong Pan China 17 528 2.0× 199 1.6× 139 1.3× 134 1.4× 53 0.6× 61 943
Stephanie A. Sullivan United States 15 150 0.6× 116 0.9× 106 1.0× 90 1.0× 68 0.8× 39 549
Yan Xue China 18 397 1.5× 140 1.1× 183 1.7× 48 0.5× 149 1.8× 47 837
Luo Yang China 14 260 1.0× 133 1.0× 105 1.0× 61 0.6× 152 1.8× 43 615
Guangping Wu China 15 239 0.9× 119 0.9× 114 1.1× 137 1.5× 129 1.6× 51 553
Zsolt Fejes Hungary 15 183 0.7× 122 1.0× 34 0.3× 84 0.9× 96 1.2× 41 612
Theresa M. Guerin United States 9 427 1.6× 204 1.6× 130 1.2× 122 1.3× 70 0.8× 16 1.1k
Z. Günnur Dikmen Türkiye 17 562 2.2× 70 0.6× 118 1.1× 43 0.5× 56 0.7× 40 974

Countries citing papers authored by Rébécca Phaëton

Since Specialization
Citations

This map shows the geographic impact of Rébécca Phaëton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rébécca Phaëton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rébécca Phaëton more than expected).

Fields of papers citing papers by Rébécca Phaëton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rébécca Phaëton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rébécca Phaëton. The network helps show where Rébécca Phaëton may publish in the future.

Co-authorship network of co-authors of Rébécca Phaëton

This figure shows the co-authorship network connecting the top 25 collaborators of Rébécca Phaëton. A scholar is included among the top collaborators of Rébécca Phaëton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rébécca Phaëton. Rébécca Phaëton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rimel, B.J., Eric Pujade‐Lauraine, Jacobus Pfisterer, et al.. (2025). Phase 3 clinical trials evaluating poly(ADP-ribose) polymerase inhibition plus immunotherapy for first-line treatment of advanced ovarian cancer. The Oncologist. 30(10).
2.
Kumari, Asha, Hao Ji, Diego Altomare, et al.. (2024). Glycosaminoglycan modifications of betaglycan regulate ectodomain shedding to fine-tune TGF-β signaling responses in ovarian cancer. Cell Communication and Signaling. 22(1). 128–128. 2 indexed citations
3.
Chang, Caroline, Sierra R. White, Katherine M. Aird, et al.. (2024). GPX3 supports ovarian cancer tumor progression in vivo and promotes expression of GDF15. Gynecologic Oncology. 185. 8–16. 4 indexed citations
4.
Monavarian, Mehri, Kathleen O’Connell, Diego Altomare, et al.. (2022). Reciprocal SOX2 regulation by SMAD1-SMAD3 is critical for anoikis resistance and metastasis in cancer. Cell Reports. 40(4). 111066–111066. 27 indexed citations
5.
Russo, Mariano, Jordan M. Newell, Kathryn Sheldon, et al.. (2020). Mutational profile of endometrial hyperplasia and risk of progression to endometrioid adenocarcinoma. Cancer. 126(12). 2775–2783. 21 indexed citations
6.
Kim, Yeon, Victoria Jones, Beth L. Worley, et al.. (2019). Context-dependent activation of SIRT3 is necessary for anchorage-independent survival and metastasis of ovarian cancer cells. Oncogene. 39(8). 1619–1633. 43 indexed citations
7.
Jiang, Zewei, Joseph Albanese, Joshua P. Kesterson, et al.. (2019). Monoclonal Antibodies Against Human Papillomavirus E6 and E7 Oncoproteins Inhibit Tumor Growth in Experimental Cervical Cancer. Translational Oncology. 12(10). 1289–1295. 16 indexed citations
8.
Worley, Beth L., Yeon Kim, Kelly E. Leon, et al.. (2018). GPx3 supports ovarian cancer progression by manipulating the extracellular redox environment. Redox Biology. 25. 101051–101051. 45 indexed citations
9.
Parisi, Laura, et al.. (2018). The role of pemetrexed in recurrent epithelial ovarian cancer: A scoping review. Oncology Reviews. 12(1). 346–346. 7 indexed citations
10.
Worley, Beth L., Yeon Kim, Kelly E. Leon, et al.. (2018). GPX3 supports ovarian cancer progression by manipulating the extracellular redox environment. Free Radical Biology and Medicine. 128. S76–S76. 1 indexed citations
11.
Gockley, Allison, et al.. (2017). The Wertheim hysterectomy: Development, modifications, and impact in the present day. Gynecologic Oncology. 145(1). 3–8. 14 indexed citations
12.
Russo, Mariano, James R. Broach, Kathryn Sheldon, et al.. (2017). Clonal evolution in paired endometrial intraepithelial neoplasia/atypical hyperplasia and endometrioid adenocarcinoma. Human Pathology. 67. 69–77. 30 indexed citations
13.
Kim, Yeon, et al.. (2017). Insights into the Dichotomous Regulation of SOD2 in Cancer. Antioxidants. 6(4). 86–86. 130 indexed citations
14.
15.
Phaëton, Rébécca, Zewei Jiang, Ekaterina Revskaya, et al.. (2015). Beta emitters rhenium‐188 and lutetium‐177 are equally effective in radioimmunotherapy of HPV‐positive experimental cervical cancer. Cancer Medicine. 5(1). 9–16. 12 indexed citations
16.
Harris, Matthew N., Zewei Jiang, Rébécca Phaëton, et al.. (2013). Combined treatment of the experimental human papilloma virus-16-positive cervical and head and neck cancers with cisplatin and radioimmunotherapy targeting viral E6 oncoprotein. British Journal of Cancer. 108(4). 859–865. 12 indexed citations
17.
Einstein, Mark H., Marina Frimer, Rébécca Phaëton, et al.. (2011). Prospective phase II trial of adjuvant pelvic radiation “sandwiched” between paclitaxel and carboplatin combination chemotherapy in women with uterine papillary serous carcinoma. Gynecologic Oncology. 120. S9–S10. 1 indexed citations
18.
Phaëton, Rébécca, Matthew N. Harris, Zewei Jiang, et al.. (2010). Radioimmunotherapy with an antibody to the HPV16 E6 oncoprotein is effective in an experimental cervical tumor expressing low levels of E6. Cancer Biology & Therapy. 10(10). 1041–1047. 10 indexed citations
19.
Einstein, Mark H. & Rébécca Phaëton. (2010). Issues in cervical cancer incidence and treatment in HIV. Current Opinion in Oncology. 22(5). 449–455. 21 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Liyan Huang Breakdown of academic impact, for papers by Qiong Pan Breakdown of academic impact, for papers by Stephanie A. Sullivan Breakdown of academic impact, for papers by Yan Xue Breakdown of academic impact, for papers by Luo Yang Breakdown of academic impact, for papers by Guangping Wu Breakdown of academic impact, for papers by Zsolt Fejes Breakdown of academic impact, for papers by Theresa M. Guerin Breakdown of academic impact, for papers by Z. Günnur Dikmen
Rankless by CCL
2026